Navigation Links
Facet Solution's AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up
Date:10/15/2007

ith results from an ongoing FDA approved IDE Study which was recently expanded to eight sites within the United States."

The summary findings from this evaluation will be presented a the Science of Facet Joint Repair and Total Posterior Arthroplasty Symposium which will be held in Austin, Texas at the Omni Hotel on Monday, October 22, 2007 at 6:30 PM.

* Note: AFRS(TM) is an investigational device in the United States. It is

limited by United States (U.S.) Federal Law for investigational use

only.

About Facet Solutions

Facet Solutions, Inc. is a privately held, venture backed company that is focused on developing and commercializing surgical devices for the treatment of facet related spinal disorders. Facet Solutions has received venture capital from its partners De Novo Ventures, Pequot Ventures, and Spray Venture Partners. Facet Solutions is FDA registered and is certified to ISO 13485.


'/>"/>
SOURCE Facet Solutions, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. The many facets of milk and its health potential
2. The Multi-Faceted Chemical Benzene
3. Multifaceted Stress: Mere thought is stressful!
4. Solutions Being Sought For Prevention Of Rickets
5. Mental Hospitals Offer More Problems than Solutions
6. Sex Workers Adopt IT Solutions to Fight AIDS
7. Bilcare Signs Pact With Honeywell for Packaging Solutions
8. Planning for Good Health Resolutions
9. Simple Solutions to Postpartum Weight Retention
10. Solutions Possible for Providing Water and Sanitation in Poor Urban Settlements, Says WaterAid
11. Silicon eye implants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... bizarre about-face, the secretive Central Intelligence Agency has requested documents ... obtained them from the CIA itself under the Freedom of ... ... December 15, 2009 -- In a bizarre about-face, the secretive ... even though the writer had earlier obtained them from the ...
(Date:12/15/2009)... Management Systems (HRMS), announced in a direct response to demand ... (APSS) to its suite of HR software, to increase productivity ... ... Mahwah, NJ (PRWEB) December 15th 2009 -- Humanic ... announced in a direct response to demand for increased technology ...
(Date:12/15/2009)... is deemed safer than wood fiber , , TUESDAY, Dec. 15 ... an arm in a fall are much lower on playgrounds ... surfaces, new research has found. , Researchers at the Hospital ... had playground surfaces of either granite sand or engineered wood ... PLoS Medicine . , The risk of a broken arm ...
(Date:12/15/2009)... for inflammatory marker may spot people in need of ... -- People with normal levels of LDL (bad) cholesterol ... inflammation in order to identify those who may benefit ... of heart attack, stroke and death, say U.S. researchers. ... JUPITER trail, which showed that statins can prevent heart ...
(Date:12/15/2009)... – Delicious Planet, Seattle’s premier organic meal delivery service ( ... its Delicious Planet Detox Program, Randi Carter, company founder and ... ... (December 15, 2009 – Seattle, WA) – Delicious Planet, Seattle’s ... orders now for the launch of its Delicious Planet Detox ...
Breaking Medicine News(10 mins):Health News:CIA Requests its Own Documents from Author 2Health News:CIA Requests its Own Documents from Author 3Health News:Humanic Design is Pleased to Announce Application Self Service (APSS) to its Product Suite to Empower Organizations with Automation 2Health News:Normal Cholesterol Doesn't Guarantee Healthy Heart 2Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 2Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 3Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 4
... is a statement by Matthew L. Myers, President, ... Energy and Commerce Committee today set Congress on ... reduce tobacco use by approving legislation granting the ... products. Today,s 39-13 vote underscores the broad, ...
... 4 National Center for Creative Aging (NCCA) will present ... as a way to engage people with dementia. The ... will be held in Washington, D.C. on March 30, ... "Cases of dementia and Alzheimer,s disease increase with age, so ...
... TSMFG.com is the Single Source Solution for Safety Supplies, Face ... Now, thanks to industry pioneer Total Source ... their contamination control needs. In the past it was necessary ... narrow range of safety supply products, ...
... of heart disease over and above any genetic risks common ... University School of Medicine in St. Louis and the VA. ... of the American Psychosomatic Society this week in Chicago. , ... twins who served in the U.S. military during the Vietnam ...
... lung cancer," but only 50 can say they,ve completed ... chances of surviving the deadly disease and without ... Radiation Oncology Department say the technique, stereotactic body radiotherapy, ... surviving early stage lung cancer, but may reduce the ...
... Watchers International, Inc. (NYSE: WTW ) today announced ... which ended January 3, 2009. Fourth Quarter 2008 Results ... $2.2 million to $346.2 million, up from $344.0 million in ... of $7.8 million to revenue, net revenues were down $5.6 ...
Other Medicine News:Health News:House Committee Vote Sets Congress on Course for Historic Regulation of Tobacco Products 2Health News:House Committee Vote Sets Congress on Course for Historic Regulation of Tobacco Products 3Health News:National Center for Creative Aging Presents 'Creativity Matters' Symposium on Health, Wellness, and the Arts 2Health News:National Center for Creative Aging Presents 'Creativity Matters' Symposium on Health, Wellness, and the Arts 3Health News:National Center for Creative Aging Presents 'Creativity Matters' Symposium on Health, Wellness, and the Arts 4Health News:Total Source Manufacturing (TSMFG.com) - A Contamination Control Pioneer 2Health News:Depression increases risk for heart disease more than genetics or environment 2Health News:Surviving lung cancer 2Health News:Weight Watchers Announces Fourth Quarter and Full Year 2008 Results 2Health News:Weight Watchers Announces Fourth Quarter and Full Year 2008 Results 3Health News:Weight Watchers Announces Fourth Quarter and Full Year 2008 Results 4Health News:Weight Watchers Announces Fourth Quarter and Full Year 2008 Results 5Health News:Weight Watchers Announces Fourth Quarter and Full Year 2008 Results 6Health News:Weight Watchers Announces Fourth Quarter and Full Year 2008 Results 7Health News:Weight Watchers Announces Fourth Quarter and Full Year 2008 Results 8Health News:Weight Watchers Announces Fourth Quarter and Full Year 2008 Results 9Health News:Weight Watchers Announces Fourth Quarter and Full Year 2008 Results 10Health News:Weight Watchers Announces Fourth Quarter and Full Year 2008 Results 11Health News:Weight Watchers Announces Fourth Quarter and Full Year 2008 Results 12Health News:Weight Watchers Announces Fourth Quarter and Full Year 2008 Results 13Health News:Weight Watchers Announces Fourth Quarter and Full Year 2008 Results 14Health News:Weight Watchers Announces Fourth Quarter and Full Year 2008 Results 15
(Date:12/15/2009)... -- ,, Reportlinker.com announces that a new ... catalogue: ,, Hepatitis B Vaccines - ... ,, http://www.reportlinker.com/p0167309/Hepatitis-B-Vaccines---Pipeline-Analysis-and-Market-Forecasts-to-2015.html ,, Hepatitis ... Forecasts to 2015 ,, Summary ... report, "Hepatitis B Vaccines - Pipeline Analysis ...
(Date:12/15/2009)... Dec. 15 Reportlinker.com announces that ... in its catalogue: ,, Boehringer Ingelheim ... ,, Introduction ,, This ... for Boehringer Ingelheim in the Rx pharmaceutical ... and pipeline analysis and assessment of financial ...
(Date:12/15/2009)... 15 Waters Corporation (NYSE: ... (v.7.1 SR4), an electronic laboratory notebook solution for ... secure electronic repository that stores and manages all ... and is used to boost efficiency in life ... SAFE-BioPharma digital identity and signature standard. The SAFE-BioPharma ...
Breaking Medicine Technology:Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 7Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 2Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 3Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 4Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 5Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 6Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 7Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 2Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 3Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 4Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 5Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 6Pharmacy Compounds Liquid Mupirocin for the Chronic Sinusitis Patient 13365 1Pharmacy Compounds Liquid Mupirocin for the Chronic Sinusitis Patient 13365 2The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 1The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 2The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 3The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 4The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 5The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 6The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 7The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 8The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 9The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 10The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 11The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results 53674 12Perrigo Company Will Release Fiscal Year 2009 Results on August 18 2009 53672 1
... 2007 - Acorda Therapeutics, Inc.(R),(Nasdaq: ACOR) today ... trial,of Fampridine-SR in people with multiple sclerosis ... Andrew Goodman, M.D.,Director of the Multiple Sclerosis ... results on walking ability, leg,strength, spasticity and ...
... in Nonclinical (IND) In- Vitro,Studies for Promising ... (PRIME NEWSWIRE) -- Samaritan,Pharmaceuticals Inc. (AMEX:LIV), a ... positive results were attained with its,late-stage preclinical/nonclinical ... models. , Although nonclinical research results are ...
Other Medicine Technology:Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 2Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 4Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 5Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 6Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 7Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 2Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: